IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines-Reference-Cited by-同舟云学术

IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines

Published:2017-09-30 Issue:61 Volume:8 Page:103465-103476
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Refolo Maria Grazia¹,D’Alessandro Rosalba¹,Lippolis Catia¹,Carella Nicola¹,Cavallini Aldo¹,Messa Caterina¹,Carr Brian Irving²

Affiliation:

1. Laboratory of Cellular and Molecular Biology, Department of Clinical Pathology, National Institute of Gastroenterology, “S. De Bellis” Research Hospital, Castellana Grotte, BA, Italy

2. Visiting Professor, Program for Targeted Experimental Therapeutics, Izmir Biomedicine and Genome Center, Dokuz Eylul University, Izmir, Turkey

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Antioxidant Vitamins and Other Micronutrients on Regulations of Specific Genes and Signaling Pathways in the Prevention and Treatment of Cancer;International Journal of Molecular Sciences;2023-03-23

2. A DECLINE IN VITAMIN K AND SOD LEVELS AND THE CHANGE IN PARP1 AND SIRT1 EXPRESSION MIGHT BE ASSOCIATED WITH PROGRESSION OF BREAST CANCER;Military Medical Science Letters;2022-12-01

3. Vitamin K Contribution to DNA Damage—Advantage or Disadvantage? A Human Health Response;Nutrients;2022-10-11

4. Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells;World Journal of Clinical Cases;2022-10-06

5. The regulation of proliferation and apoptosis in hepatocellular carcinoma via insulin-like growth factor 1 receptor;Growth Hormone & IGF Research;2022-10